Electromed (ELMD) Competitors $19.65 -0.70 (-3.44%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$19.60 -0.04 (-0.23%) As of 05/23/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock ELMD vs. IRMD, EMBC, RXST, BBNX, CBLL, DCTH, AVNS, BFLY, BVS, and KIDSShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Iradimed (IRMD), Embecta (EMBC), RxSight (RXST), Beta Bionics (BBNX), CeriBell (CBLL), Delcath Systems (DCTH), Avanos Medical (AVNS), Butterfly Network (BFLY), Bioventus (BVS), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Electromed vs. Iradimed Embecta RxSight Beta Bionics CeriBell Delcath Systems Avanos Medical Butterfly Network Bioventus OrthoPediatrics Iradimed (NASDAQ:IRMD) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, community ranking, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends. Which has higher valuation & earnings, IRMD or ELMD? Iradimed has higher revenue and earnings than Electromed. Electromed is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIradimed$75.15M8.64$19.23M$1.5532.96Electromed$61.44M2.68$5.15M$0.7924.87 Does the media prefer IRMD or ELMD? In the previous week, Electromed had 2 more articles in the media than Iradimed. MarketBeat recorded 4 mentions for Electromed and 2 mentions for Iradimed. Iradimed's average media sentiment score of 1.83 beat Electromed's score of 1.36 indicating that Iradimed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iradimed 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Electromed 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer IRMD or ELMD? Iradimed currently has a consensus price target of $72.00, indicating a potential upside of 40.93%. Electromed has a consensus price target of $38.00, indicating a potential upside of 93.38%. Given Electromed's stronger consensus rating and higher probable upside, analysts clearly believe Electromed is more favorable than Iradimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iradimed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has more risk & volatility, IRMD or ELMD? Iradimed has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Electromed has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500. Do insiders & institutionals believe in IRMD or ELMD? 92.3% of Iradimed shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 36.8% of Iradimed shares are held by company insiders. Comparatively, 14.0% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor IRMD or ELMD? Iradimed received 236 more outperform votes than Electromed when rated by MarketBeat users. However, 92.59% of users gave Electromed an outperform vote while only 65.58% of users gave Iradimed an outperform vote. CompanyUnderperformOutperformIradimedOutperform Votes26165.58% Underperform Votes13734.42% ElectromedOutperform Votes2592.59% Underperform Votes27.41% Is IRMD or ELMD more profitable? Iradimed has a net margin of 26.26% compared to Electromed's net margin of 11.34%. Iradimed's return on equity of 24.12% beat Electromed's return on equity.Company Net Margins Return on Equity Return on Assets Iradimed26.26% 24.12% 21.20% Electromed 11.34%15.71%13.37% SummaryIradimed beats Electromed on 14 of the 19 factors compared between the two stocks. Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$164.79M$3.21B$5.34B$19.26BDividend YieldN/A1.73%5.27%3.85%P/E Ratio26.2017.6426.9634.42Price / Sales2.68170.66398.8134.83Price / Cash41.3646.8438.3217.51Price / Book3.853.746.774.69Net Income$5.15M$95.96M$3.24B$1.02B7 Day Performance-8.82%1.61%0.27%-2.38%1 Month Performance-14.79%13.67%5.91%4.18%1 Year Performance18.02%-8.63%18.83%4.87% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromed1.3774 of 5 stars$19.65-3.4%$38.00+93.4%+18.0%$164.79M$61.44M26.20160Positive NewsGap DownIRMDIradimed4.8914 of 5 stars$54.21+0.6%$72.00+32.8%+20.6%$689.28M$75.15M36.14110Positive NewsEx-DividendEMBCEmbecta4.4314 of 5 stars$11.62-3.3%$20.33+75.0%-18.4%$679.11M$1.08B11.621,900News CoveragePositive NewsAnalyst UpgradeInsider TradeRXSTRxSight2.9482 of 5 stars$16.32+15.0%$37.90+132.2%-74.4%$663.20M$148.31M-19.66220News CoveragePositive NewsGap UpHigh Trading VolumeBBNXBeta BionicsN/A$15.10+5.2%$24.83+64.5%N/A$654.68M$69.83M0.00294CBLLCeriBell2.7147 of 5 stars$17.83-0.8%$32.50+82.3%N/A$644.43M$71.54M0.00N/APositive NewsDCTHDelcath Systems3.204 of 5 stars$18.10+5.8%$22.75+25.7%+107.1%$630.35M$53.85M-13.4160News CoveragePositive NewsAnalyst ForecastAnalyst RevisionAVNSAvanos Medical2.6636 of 5 stars$13.00-0.8%N/A-38.3%$601.17M$689.20M38.244,040Positive NewsBFLYButterfly Network2.6422 of 5 stars$2.32-1.3%$4.00+72.4%+115.8%$573.71M$85.63M-5.04460Positive NewsGap DownBVSBioventus3.2324 of 5 stars$6.93+2.1%$14.33+106.8%+2.5%$567.87M$567.70M-11.361,200Positive NewsKIDSOrthoPediatrics4.6061 of 5 stars$22.95-0.5%$35.83+56.1%-36.0%$557.39M$212.45M-18.66200 Related Companies and Tools Related Companies IRMD Competitors EMBC Competitors RXST Competitors BBNX Competitors CBLL Competitors DCTH Competitors AVNS Competitors BFLY Competitors BVS Competitors KIDS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELMD) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
